Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.

about

Gynecology and Obstetrics has Entered Modern Times: Perspectives and Challenges.

P2860

Q34868356-8DFD7B5B-FB14-4DBE-9A2D-9FA5687F3BC9

P2860

Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.

Item

http://www.wikidata.org/entity/Q45885814

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Engraftment of genetically mod ...... utero transplantation in mice.

@en

Engraftment of genetically mod ...... utero transplantation in mice.

@nl

type

Item

label

Engraftment of genetically mod ...... utero transplantation in mice.

@en

Engraftment of genetically mod ...... utero transplantation in mice.

@nl

prefLabel

Engraftment of genetically mod ...... utero transplantation in mice.

@en

Engraftment of genetically mod ...... utero transplantation in mice.

@nl

P1476

Engraftment of genetically mod ...... utero transplantation in mice.

@en

P2093

Chen-Min Yang

http://www.w3.org/2001/XMLSchema#string

Fanyi Zeng

http://www.w3.org/2001/XMLSchema#string

Hui-Xiang Tang

http://www.w3.org/2001/XMLSchema#string

Jin Qiu

http://www.w3.org/2001/XMLSchema#string

Shu-Zhen Huang

http://www.w3.org/2001/XMLSchema#string

Xiu-Li Gong

http://www.w3.org/2001/XMLSchema#string

Zhi-Juan Gong

http://www.w3.org/2001/XMLSchema#string

P2860

Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice

Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol.

Molecular and proteomic characterization of human mesenchymal stem cells derived from amniotic fluid: comparison to bone marrow mesenchymal stem cells.

Advances toward gene therapy for hemophilia at the millennium.

Factor IX ectopically expressed in platelets can be stored in alpha-granules and corrects the phenotype of hemophilia B mice.

Actively acquired tolerance of foreign cells.

Genetic engineering of mesenchymal stem cells and its application in human disease therapy.

Lentivirus-mediated platelet-derived factor VIII gene therapy in murine haemophilia A.

Multiorgan engraftment and differentiation of human cord blood CD34+ Lin- cells in goats assessed by gene expression profiling.

Gene therapy of the hemophilias.

P304

420-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CBIN.10037

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23504762

http://www.w3.org/2001/XMLSchema#string

Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.

about

P2860

P2860

Engraftment of genetically modified human amniotic fluid-derived progenitor cells to produce coagulation factor IX after in utero transplantation in mice.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698